Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-10-02

AUTHORS

Michael Dagmar, David G Beer, Charles W Wilke, Diane E Miller, Thomas W Glover

ABSTRACT

The FHIT gene, which spans the common fragile site FRA3B, has been shown to produce aberrant transcripts in a variety of tumor types. Homozygous deletions within the FHIT locus have been detected only in tumor-derived cell lines and LOH has been described in numerous primary tumors. Based on these findings and its location on 3p, FHIT has been proposed as a tumor suppressor gene. To further study the relationship of FRA3B to the findings regarding the FHIT gene and to determine the extent of FHIT mRNA alterations in early stages of tumor development, the status of the FHIT gene was evaluated in the premalignant condition of Barrett's esophagus and associated esophageal adenocarcinomas. FHIT expression was investigated by RT – PCR in normal esophageal, Barrett's metaplasia and adenocarcinoma tissues from 15 patients. Alterations of FHIT transcripts were observed in 12/14 (86%) of Barrett's metaplasia and in 14/15 (93%) of the adenocarcinomas from the same patients. Characterization of the altered transcripts revealed FHIT mRNA lacking one or more exons, with deletion of exons 5 – 7 being most frequent. Analysis of genomic DNA from 20 patients showed homozygous deletions involving exon 5 of FHIT in 4/20 (20%) esophageal adenocarcinomas, and 7/20 (35%) tumors demonstrated hemizygous loss. Genomic deletions also involved the BE758-6 locus, indicating that a large region is deleted. Fluorescence in situ hybridization (FISH) analysis demonstrated that this region of deletion is localized within FRA3B. Our results extend the range of tumor types in which altered FHIT transcripts have been demonstrated and show that these alterations can be seen in the premalignant stage of esophageal tumor development. These results indicate that the fragility and recombination-prone nature of FRA3B is related to tumor-specific chromosomal instability affecting the FHIT gene in esophageal adenocarcinoma development. More... »

PAGES

1653-1659

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1201330

DOI

http://dx.doi.org/10.1038/sj.onc.1201330

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021054976

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9349498


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acid Anhydride Hydrolases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Barrett Esophagus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Fragile Sites", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Fragility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Mapping", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosomes, Human, Pair 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Esophageal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Deletion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Hybridization, Fluorescence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Neoplasm", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Innere Klinik (Tumorferschung), Hulelandstr. 55, 45122, Essen, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA", 
            "Innere Klinik (Tumorferschung), Hulelandstr. 55, 45122, Essen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dagmar", 
        "givenName": "Michael", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Section of Thoracic Surgery, University of Michigan, 48109, Ann Arbor, Michigan, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Department of Surgery, Section of Thoracic Surgery, University of Michigan, 48109, Ann Arbor, Michigan, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beer", 
        "givenName": "David G", 
        "id": "sg:person.01275756744.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275756744.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilke", 
        "givenName": "Charles W", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miller", 
        "givenName": "Diane E", 
        "id": "sg:person.01140032143.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140032143.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Glover", 
        "givenName": "Thomas W", 
        "id": "sg:person.0734760120.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734760120.41"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1997-10-02", 
    "datePublishedReg": "1997-10-02", 
    "description": "The FHIT gene, which spans the common fragile site FRA3B, has been shown to produce aberrant transcripts in a variety of tumor types. Homozygous deletions within the FHIT locus have been detected only in tumor-derived cell lines and LOH has been described in numerous primary tumors. Based on these findings and its location on 3p, FHIT has been proposed as a tumor suppressor gene. To further study the relationship of FRA3B to the findings regarding the FHIT gene and to determine the extent of FHIT mRNA alterations in early stages of tumor development, the status of the FHIT gene was evaluated in the premalignant condition of Barrett's esophagus and associated esophageal adenocarcinomas. FHIT expression was investigated by RT\u2009\u2013\u2009PCR in normal esophageal, Barrett's metaplasia and adenocarcinoma tissues from 15 patients. Alterations of FHIT transcripts were observed in 12/14 (86%) of Barrett's metaplasia and in 14/15 (93%) of the adenocarcinomas from the same patients. Characterization of the altered transcripts revealed FHIT mRNA lacking one or more exons, with deletion of exons 5\u2009\u2013\u20097 being most frequent. Analysis of genomic DNA from 20 patients showed homozygous deletions involving exon 5 of FHIT in 4/20 (20%) esophageal adenocarcinomas, and 7/20 (35%) tumors demonstrated hemizygous loss. Genomic deletions also involved the BE758-6 locus, indicating that a large region is deleted. Fluorescence in situ hybridization (FISH) analysis demonstrated that this region of deletion is localized within FRA3B. Our results extend the range of tumor types in which altered FHIT transcripts have been demonstrated and show that these alterations can be seen in the premalignant stage of esophageal tumor development. These results indicate that the fragility and recombination-prone nature of FRA3B is related to tumor-specific chromosomal instability affecting the FHIT gene in esophageal adenocarcinoma development.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1201330", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2469147", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2472758", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "14", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "FHIT gene", 
      "Barrett's metaplasia", 
      "common fragile site FRA3B", 
      "fragile site FRA3B", 
      "tumor-derived cell lines", 
      "tumor suppressor gene", 
      "tumor development", 
      "homozygous deletion", 
      "FHIT transcripts", 
      "tumor types", 
      "situ hybridization analysis", 
      "exon 5", 
      "aberrant transcripts", 
      "altered transcripts", 
      "genomic DNA", 
      "chromosomal instability", 
      "suppressor gene", 
      "genomic deletions", 
      "hybridization analysis", 
      "esophageal tumor development", 
      "esophageal adenocarcinoma development", 
      "genes", 
      "FRA3B", 
      "transcripts", 
      "deletion", 
      "frequent deletions", 
      "FHIT locus", 
      "cell lines", 
      "primary tumor", 
      "premalignant condition", 
      "hemizygous loss", 
      "mRNA alterations", 
      "Barrett's esophagus", 
      "region of deletion", 
      "adenocarcinoma development", 
      "FHIT", 
      "metaplasia", 
      "same patient", 
      "loci", 
      "FHIT expression", 
      "normal esophageal", 
      "adenocarcinoma tissues", 
      "more exons", 
      "premalignant stages", 
      "patients", 
      "adenocarcinoma", 
      "FHIT mRNA", 
      "esophagus", 
      "tumors", 
      "alterations", 
      "exons", 
      "DNA", 
      "mRNA", 
      "early stages", 
      "expression", 
      "esophageal", 
      "PCR", 
      "large regions", 
      "findings", 
      "region", 
      "LOH", 
      "stage", 
      "development", 
      "tissue", 
      "fluorescence", 
      "status", 
      "lines", 
      "characterization", 
      "RT", 
      "analysis", 
      "variety", 
      "types", 
      "loss", 
      "fragility", 
      "results", 
      "extent", 
      "relationship", 
      "location", 
      "conditions", 
      "range", 
      "nature", 
      "instability"
    ], 
    "name": "Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas", 
    "pagination": "1653-1659", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021054976"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1201330"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9349498"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1201330", 
      "https://app.dimensions.ai/details/publication/pub.1021054976"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_289.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1201330"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201330'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201330'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201330'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201330'


 

This table displays all metadata directly associated to this object as RDF triples.

243 TRIPLES      20 PREDICATES      123 URIs      114 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1201330 schema:about N53e14acbeb2d4bb9a8983705be2d88fd
2 N55285372c4bf4350a5c3f90e0b01e59e
3 N56d4983d680d4dae96d196362682ae27
4 N8419bb51da4341c89db6362ba3e67048
5 N8de2aa96562d49baa5f193fa0a7140d5
6 N8f1672c74003402e90162a8b23e82683
7 N9df45a237e044ea1a3dc0b81be72b90f
8 Nb3387ee176e047a9870f6a2aa02208da
9 Nb603f3956d584423befd332de40c2d97
10 Nbe43e440d8e549cbb5a7259c088849e6
11 Nc2f6012a51364126be1e12f777b06e9b
12 Nc36f5b655c534976881c4bcab97acf8a
13 Nc56b07ee4bd841c385c1a7dec2187c14
14 Nd0546ab002cd4117a8585fb8c106fc6c
15 Nd57e6bd1275749b4b2cf9d3c2f7cd664
16 anzsrc-for:11
17 anzsrc-for:1103
18 anzsrc-for:1112
19 schema:author Na3e04a62a49a4893b128aa47906a07ea
20 schema:datePublished 1997-10-02
21 schema:datePublishedReg 1997-10-02
22 schema:description The FHIT gene, which spans the common fragile site FRA3B, has been shown to produce aberrant transcripts in a variety of tumor types. Homozygous deletions within the FHIT locus have been detected only in tumor-derived cell lines and LOH has been described in numerous primary tumors. Based on these findings and its location on 3p, FHIT has been proposed as a tumor suppressor gene. To further study the relationship of FRA3B to the findings regarding the FHIT gene and to determine the extent of FHIT mRNA alterations in early stages of tumor development, the status of the FHIT gene was evaluated in the premalignant condition of Barrett's esophagus and associated esophageal adenocarcinomas. FHIT expression was investigated by RT – PCR in normal esophageal, Barrett's metaplasia and adenocarcinoma tissues from 15 patients. Alterations of FHIT transcripts were observed in 12/14 (86%) of Barrett's metaplasia and in 14/15 (93%) of the adenocarcinomas from the same patients. Characterization of the altered transcripts revealed FHIT mRNA lacking one or more exons, with deletion of exons 5 – 7 being most frequent. Analysis of genomic DNA from 20 patients showed homozygous deletions involving exon 5 of FHIT in 4/20 (20%) esophageal adenocarcinomas, and 7/20 (35%) tumors demonstrated hemizygous loss. Genomic deletions also involved the BE758-6 locus, indicating that a large region is deleted. Fluorescence in situ hybridization (FISH) analysis demonstrated that this region of deletion is localized within FRA3B. Our results extend the range of tumor types in which altered FHIT transcripts have been demonstrated and show that these alterations can be seen in the premalignant stage of esophageal tumor development. These results indicate that the fragility and recombination-prone nature of FRA3B is related to tumor-specific chromosomal instability affecting the FHIT gene in esophageal adenocarcinoma development.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N8ccea8e57b7b4a80a01d91e0600dda44
26 Nc02ca526a91e42cebd4f12225ec239f0
27 sg:journal.1097543
28 schema:keywords Barrett's esophagus
29 Barrett's metaplasia
30 DNA
31 FHIT
32 FHIT expression
33 FHIT gene
34 FHIT locus
35 FHIT mRNA
36 FHIT transcripts
37 FRA3B
38 LOH
39 PCR
40 RT
41 aberrant transcripts
42 adenocarcinoma
43 adenocarcinoma development
44 adenocarcinoma tissues
45 alterations
46 altered transcripts
47 analysis
48 cell lines
49 characterization
50 chromosomal instability
51 common fragile site FRA3B
52 conditions
53 deletion
54 development
55 early stages
56 esophageal
57 esophageal adenocarcinoma development
58 esophageal tumor development
59 esophagus
60 exon 5
61 exons
62 expression
63 extent
64 findings
65 fluorescence
66 fragile site FRA3B
67 fragility
68 frequent deletions
69 genes
70 genomic DNA
71 genomic deletions
72 hemizygous loss
73 homozygous deletion
74 hybridization analysis
75 instability
76 large regions
77 lines
78 location
79 loci
80 loss
81 mRNA
82 mRNA alterations
83 metaplasia
84 more exons
85 nature
86 normal esophageal
87 patients
88 premalignant condition
89 premalignant stages
90 primary tumor
91 range
92 region
93 region of deletion
94 relationship
95 results
96 same patient
97 situ hybridization analysis
98 stage
99 status
100 suppressor gene
101 tissue
102 transcripts
103 tumor development
104 tumor suppressor gene
105 tumor types
106 tumor-derived cell lines
107 tumors
108 types
109 variety
110 schema:name Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas
111 schema:pagination 1653-1659
112 schema:productId N18fdee3d28e24089a0e868d3ad44db6d
113 N7896f9ebf1bd48ba9401c6800b87e1b5
114 Nc7db83f7ccea4c6b99dc7b7b4244d349
115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021054976
116 https://doi.org/10.1038/sj.onc.1201330
117 schema:sdDatePublished 2022-09-02T15:47
118 schema:sdLicense https://scigraph.springernature.com/explorer/license/
119 schema:sdPublisher N0e33371f64094c4da95c1f1ce33216ee
120 schema:url https://doi.org/10.1038/sj.onc.1201330
121 sgo:license sg:explorer/license/
122 sgo:sdDataset articles
123 rdf:type schema:ScholarlyArticle
124 N0e33371f64094c4da95c1f1ce33216ee schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N18fdee3d28e24089a0e868d3ad44db6d schema:name doi
127 schema:value 10.1038/sj.onc.1201330
128 rdf:type schema:PropertyValue
129 N39343b50273b4be1b526a508b2cd94ba rdf:first Nef6b2d19e6134947b8cb65bc35ef79ac
130 rdf:rest Nc2b13f7cc97041728093104d5568ae60
131 N47ca3e5eb0a343b19d497808e0954694 schema:affiliation grid-institutes:None
132 schema:familyName Dagmar
133 schema:givenName Michael
134 rdf:type schema:Person
135 N53e14acbeb2d4bb9a8983705be2d88fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Chromosome Fragility
137 rdf:type schema:DefinedTerm
138 N55285372c4bf4350a5c3f90e0b01e59e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Esophageal Neoplasms
140 rdf:type schema:DefinedTerm
141 N56d4983d680d4dae96d196362682ae27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Gene Deletion
143 rdf:type schema:DefinedTerm
144 N7896f9ebf1bd48ba9401c6800b87e1b5 schema:name dimensions_id
145 schema:value pub.1021054976
146 rdf:type schema:PropertyValue
147 N8419bb51da4341c89db6362ba3e67048 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 N8ccea8e57b7b4a80a01d91e0600dda44 schema:volumeNumber 15
151 rdf:type schema:PublicationVolume
152 N8de2aa96562d49baa5f193fa0a7140d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Adenocarcinoma
154 rdf:type schema:DefinedTerm
155 N8f1672c74003402e90162a8b23e82683 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Acid Anhydride Hydrolases
157 rdf:type schema:DefinedTerm
158 N9df45a237e044ea1a3dc0b81be72b90f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Chromosome Fragile Sites
160 rdf:type schema:DefinedTerm
161 Na3e04a62a49a4893b128aa47906a07ea rdf:first N47ca3e5eb0a343b19d497808e0954694
162 rdf:rest Nab160becfb634dc5b67e283018f11423
163 Nab160becfb634dc5b67e283018f11423 rdf:first sg:person.01275756744.69
164 rdf:rest N39343b50273b4be1b526a508b2cd94ba
165 Nb3387ee176e047a9870f6a2aa02208da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Chromosome Mapping
167 rdf:type schema:DefinedTerm
168 Nb603f3956d584423befd332de40c2d97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name RNA, Neoplasm
170 rdf:type schema:DefinedTerm
171 Nbe43e440d8e549cbb5a7259c088849e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name In Situ Hybridization, Fluorescence
173 rdf:type schema:DefinedTerm
174 Nc02ca526a91e42cebd4f12225ec239f0 schema:issueNumber 14
175 rdf:type schema:PublicationIssue
176 Nc2b13f7cc97041728093104d5568ae60 rdf:first sg:person.01140032143.16
177 rdf:rest Nc3aa685a753f426b9a62fd5262912507
178 Nc2f6012a51364126be1e12f777b06e9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Barrett Esophagus
180 rdf:type schema:DefinedTerm
181 Nc36f5b655c534976881c4bcab97acf8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name RNA, Messenger
183 rdf:type schema:DefinedTerm
184 Nc3aa685a753f426b9a62fd5262912507 rdf:first sg:person.0734760120.41
185 rdf:rest rdf:nil
186 Nc56b07ee4bd841c385c1a7dec2187c14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Neoplasm Proteins
188 rdf:type schema:DefinedTerm
189 Nc7db83f7ccea4c6b99dc7b7b4244d349 schema:name pubmed_id
190 schema:value 9349498
191 rdf:type schema:PropertyValue
192 Nd0546ab002cd4117a8585fb8c106fc6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Chromosomes, Human, Pair 3
194 rdf:type schema:DefinedTerm
195 Nd57e6bd1275749b4b2cf9d3c2f7cd664 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Proteins
197 rdf:type schema:DefinedTerm
198 Nef6b2d19e6134947b8cb65bc35ef79ac schema:affiliation grid-institutes:grid.214458.e
199 schema:familyName Wilke
200 schema:givenName Charles W
201 rdf:type schema:Person
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
206 schema:name Clinical Sciences
207 rdf:type schema:DefinedTerm
208 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
209 schema:name Oncology and Carcinogenesis
210 rdf:type schema:DefinedTerm
211 sg:grant.2469147 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1201330
212 rdf:type schema:MonetaryGrant
213 sg:grant.2472758 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1201330
214 rdf:type schema:MonetaryGrant
215 sg:journal.1097543 schema:issn 0950-9232
216 1476-5594
217 schema:name Oncogene
218 schema:publisher Springer Nature
219 rdf:type schema:Periodical
220 sg:person.01140032143.16 schema:affiliation grid-institutes:grid.214458.e
221 schema:familyName Miller
222 schema:givenName Diane E
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140032143.16
224 rdf:type schema:Person
225 sg:person.01275756744.69 schema:affiliation grid-institutes:grid.214458.e
226 schema:familyName Beer
227 schema:givenName David G
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275756744.69
229 rdf:type schema:Person
230 sg:person.0734760120.41 schema:affiliation grid-institutes:grid.214458.e
231 schema:familyName Glover
232 schema:givenName Thomas W
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734760120.41
234 rdf:type schema:Person
235 grid-institutes:None schema:alternateName Innere Klinik (Tumorferschung), Hulelandstr. 55, 45122, Essen, Germany
236 schema:name Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA
237 Innere Klinik (Tumorferschung), Hulelandstr. 55, 45122, Essen, Germany
238 rdf:type schema:Organization
239 grid-institutes:grid.214458.e schema:alternateName Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA
240 Department of Surgery, Section of Thoracic Surgery, University of Michigan, 48109, Ann Arbor, Michigan, USA
241 schema:name Department of Human Genetics and Pediatrics, University of Michigan, 48109, Ann Arbor, Michigan, USA
242 Department of Surgery, Section of Thoracic Surgery, University of Michigan, 48109, Ann Arbor, Michigan, USA
243 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...